- Home
- MNY vs MAIA Comparison
MNY vs MAIA Comparison
Compare MNY & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNY
- MAIA
- Stock Information
- Founded
- MNY 2014
- MAIA 2018
- Country
- MNY Singapore
- MAIA United States
- Employees
- MNY N/A
- MAIA N/A
- Industry
- MNY
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- MNY
- MAIA Health Care
- Exchange
- MNY Nasdaq
- MAIA Nasdaq
- Market Cap
- MNY 45.1M
- MAIA 52.8M
- IPO Year
- MNY N/A
- MAIA 2022
- Fundamental
- Price
- MNY $1.11
- MAIA $2.00
- Analyst Decision
- MNY
- MAIA
- Analyst Count
- MNY 0
- MAIA 0
- Target Price
- MNY N/A
- MAIA N/A
- AVG Volume (30 Days)
- MNY 72.6K
- MAIA 346.7K
- Earning Date
- MNY 12-10-2024
- MAIA 11-12-2024
- Dividend Yield
- MNY N/A
- MAIA N/A
- EPS Growth
- MNY N/A
- MAIA N/A
- EPS
- MNY N/A
- MAIA N/A
- Revenue
- MNY $90,185,081.00
- MAIA N/A
- Revenue This Year
- MNY $18.50
- MAIA N/A
- Revenue Next Year
- MNY $24.83
- MAIA N/A
- P/E Ratio
- MNY N/A
- MAIA N/A
- Revenue Growth
- MNY 24.60
- MAIA N/A
- 52 Week Low
- MNY $0.85
- MAIA $1.17
- 52 Week High
- MNY $3.46
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- MNY 49.05
- MAIA 44.72
- Support Level
- MNY $1.07
- MAIA $1.97
- Resistance Level
- MNY $1.13
- MAIA $2.44
- Average True Range (ATR)
- MNY 0.05
- MAIA 0.20
- MACD
- MNY 0.00
- MAIA 0.00
- Stochastic Oscillator
- MNY 36.05
- MAIA 8.33
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.